285 related articles for article (PubMed ID: 20725990)
1. Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.
McBride DJ; Orpana AK; Sotiriou C; Joensuu H; Stephens PJ; Mudie LJ; Hämäläinen E; Stebbings LA; Andersson LC; Flanagan AM; Durbecq V; Ignatiadis M; Kallioniemi O; Heckman CA; Alitalo K; Edgren H; Futreal PA; Stratton MR; Campbell PJ
Genes Chromosomes Cancer; 2010 Nov; 49(11):1062-9. PubMed ID: 20725990
[TBL] [Abstract][Full Text] [Related]
2. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
[TBL] [Abstract][Full Text] [Related]
3. Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
Tang MH; Dahlgren M; Brueffer C; Tjitrowirjo T; Winter C; Chen Y; Olsson E; Wang K; Törngren T; Sjöström M; Grabau D; Bendahl PO; Rydén L; Niméus E; Saal LH; Borg Å; Gruvberger-Saal SK
Oncotarget; 2015 Nov; 6(35):37169-84. PubMed ID: 26439695
[TBL] [Abstract][Full Text] [Related]
4. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations.
Lorenz S; Barøy T; Sun J; Nome T; Vodák D; Bryne JC; Håkelien AM; Fernandez-Cuesta L; Möhlendick B; Rieder H; Szuhai K; Zaikova O; Ahlquist TC; Thomassen GO; Skotheim RI; Lothe RA; Tarpey PS; Campbell P; Flanagan A; Myklebost O; Meza-Zepeda LA
Oncotarget; 2016 Feb; 7(5):5273-88. PubMed ID: 26672768
[TBL] [Abstract][Full Text] [Related]
5. Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
McVeigh TP; Cody N; Carroll C; Duff M; Farrell M; Bradley L; Gallagher D; McDevitt T; Green AJ
Cancer Genet; 2017 Aug; 214-215():1-8. PubMed ID: 28595730
[TBL] [Abstract][Full Text] [Related]
6. Somatic structural rearrangements in genetically engineered mouse mammary tumors.
Varela I; Klijn C; Stephens PJ; Mudie LJ; Stebbings L; Galappaththige D; van der Gulden H; Schut E; Klarenbeek S; Campbell PJ; Wessels LF; Stratton MR; Jonkers J; Futreal PA; Adams DJ
Genome Biol; 2010; 11(10):R100. PubMed ID: 20942901
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive genotyping and monitoring of anaplastic lymphoma kinase (ALK) rearranged non-small cell lung cancer by capture-based next-generation sequencing.
Wang Y; Tian PW; Wang WY; Wang K; Zhang Z; Chen BJ; He YQ; Li L; Liu H; Chuai S; Li WM
Oncotarget; 2016 Oct; 7(40):65208-65217. PubMed ID: 27564104
[TBL] [Abstract][Full Text] [Related]
8. Digital PCR of Genomic Rearrangements for Monitoring Circulating Tumour DNA.
Do H; Cameron D; Molania R; Thapa B; Rivalland G; Mitchell PL; Murone C; John T; Papenfuss A; Dobrovic A
Adv Exp Med Biol; 2016; 924():139-146. PubMed ID: 27753035
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of paired-end sequencing strategies for detection of genome rearrangements in cancer.
Bashir A; Volik S; Collins C; Bafna V; Raphael BJ
PLoS Comput Biol; 2008 Apr; 4(4):e1000051. PubMed ID: 18404202
[TBL] [Abstract][Full Text] [Related]
10. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations.
Agata S; Viel A; Della Puppa L; Cortesi L; Fersini G; Callegaro M; Dalla Palma M; Dolcetti R; Federico M; Venuta S; Miolo G; D'Andrea E; Montagna M
Genes Chromosomes Cancer; 2006 Sep; 45(9):791-7. PubMed ID: 16715518
[TBL] [Abstract][Full Text] [Related]
12. Novel BRCA1 Large Genomic Rearrangements in Italian Breast/Ovarian Cancer Patients.
Rizza R; Hackmann K; Paris I; Minucci A; De Leo R; Schrock E; Urbani A; Capoluongo E; Gelli G; Concolino P
Mol Diagn Ther; 2019 Feb; 23(1):121-126. PubMed ID: 30506513
[TBL] [Abstract][Full Text] [Related]
13. Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Fumagalli C; Ranghiero A; Gandini S; Corso F; Taormina S; De Camilli E; Rappa A; Vacirca D; Viale G; Guerini-Rocco E; Barberis M
Breast Cancer Res; 2020 Oct; 22(1):107. PubMed ID: 33059724
[TBL] [Abstract][Full Text] [Related]
14. Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes.
McBride DJ; Etemadmoghadam D; Cooke SL; Alsop K; George J; Butler A; Cho J; Galappaththige D; Greenman C; Howarth KD; Lau KW; Ng CK; Raine K; Teague J; Wedge DC; Cancer Study Group AO; Caubit X; Stratton MR; Brenton JD; Campbell PJ; Futreal PA; Bowtell DD
J Pathol; 2012 Aug; 227(4):446-55. PubMed ID: 22514011
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel large genomic rearrangements at the BRCA1 locus in Malaysian women with breast cancer.
Sharifah NA; Nurismah MI; Lee HC; Aisyah AN; Clarence-Ko CH; Naqiyah I; Rohaizak M; Fuad I; A Jamal AR; Zarina AL; Nor Aina E; Normayah K; Nor Hisham A
Cancer Epidemiol; 2010 Aug; 34(4):442-7. PubMed ID: 20451485
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
17. [Molecular targeted therapy and genomic evolution of breast cancer].
Sato F; Toi M
Nihon Rinsho; 2015 Aug; 73(8):1364-72. PubMed ID: 26281691
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
[TBL] [Abstract][Full Text] [Related]
19. Genomic tumor evolution of breast cancer.
Sato F; Saji S; Toi M
Breast Cancer; 2016 Jan; 23(1):4-11. PubMed ID: 25998191
[TBL] [Abstract][Full Text] [Related]
20. The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next-generation sequencing.
Jones MA; Timms KM; Hatcher S; Cogan ES; Comeaux MS; Perry M; Morris B; Swedlund B; Elks CE; Lao-Sirieix P; Dearden S; Egile C; Brown JS; Harrington EA; Hodgson D; Stern M; Slavin TP; Mancini-DiNardo D
Genes Chromosomes Cancer; 2023 Oct; 62(10):589-596. PubMed ID: 37222498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
